About Us

Our Mission

Pioneering a new class of treatments for neuro-visual disorders.

Around 15 million Americans suffer from vision loss caused by deficiencies in the brain, instead of any structural issues with the eyes. Traditional therapeutic modalities are unable to properly target and treat these deficits, leaving a significant unmet need.

By harnessing the latest in digital technology, we're creating an entirely new category of medicines to address these conditions. We develop software products that generate therapeutic visual stimuli and deliver them to the patient through a virtual reality headset, using the eyes to stimulate the brain. The success of our amblyopia therapeutic provides proof-of-concept for our broader platform.

Development Pipeline

Press Releases

Follow along with our latest news.
For press inquiries, please contact pr@luminopia.com


To achieve our mission, we've brought together a world-class team with deep experience and a true passion for helping patients.

Co-Founder and CEO

MIT TR Innovators Under 35
Forbes 30 Under 30


Former CCO at Clearside Biomedical
Former Director at Genentech


Former VP of Digital at Evelo Biosciences
Former Director at Biogen

VP of Clinical Development

Former Director at Ora
Biomedical Engineer

Head of Engineering

Former VP of Technology at Moth+Flame
Former SVP of Technology at Littlstar

VP of Commercial

Former GM of Dompe Canada
Former Sr. Director Clearside Biomedical and Santen

Board Of Directors

We're proud to have the support of an exceptional Board of Directors, with leaders from across healthcare, tech, and entertainment.

Robert Langer, ScD

Institute Professor at MIT;
Co-Founder of Moderna;
Most cited engineer in history

Michelle Kydd Lee

Chief Innovation Officer at CAA;
Co-Founder of TIME’S UP

Jeffrey Dunn

Executive Chairman at Sesame Workshop;
Former COO of Nickelodeon

Mark Jacobstein

Executive Business Advisor at Immunai
Former CUEO at Guardant Health

William Dai

Founding Managing Partner at ShangBay Capital;
Former CFO at Boston Scientific China

Co-Founder and Chairman

Thiel Fellow
Forbes 30 Under 30

Co-Founder and CEO

MIT TR Innovators Under 35
Forbes 30 Under 30


We're grateful to have the backing of several top-tier investment firms who share our vision for the future.

Platform Scientific Advisors

We're thrilled to have a group of renowned clinicians and scientists guiding the development of our platform.

Peter J. McDonnell, MD

Director of The Wilmer Eye Institute

Marguerite McDonald, MD, FACS

Clinical Professor of Ophthalmology

New York University
Langone Medical Center

Peter Bex, PhD

Chair of Psychology

Northeastern University

Krystel Huxlin, PhD

Professor of Ophthalmology

University of Rochester

Eric Singman, MD

Professor of Ophthalmology

University of Maryland